Cellectis Inc. (CLLS) Q3 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Cellectis S.a..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.029 -- 00:00:05.570 Good morning, everyone, and welcome to the Selectix third quarter 2023 earnings 00:00:05.570 -- 00:00:10.351 call. At this time, all participants are in a listen-only mode. 00:00:10.351 -- 00:00:14.912 Later, we will conduct a question-and-answer session, and instructions will follow at 00:00:14.912 -- 00:00:20.994 that time. Please be aware that today's conference call is being recorded. 00:00:20.994 -- 00:00:26.795 I'd now like to introduce our first speaker, Arthur Strill, Chief Business Officer. 00:00:26.795 -- 00:00:29.095 You may begin. 00:00:29.844 -- 00:00:35.346 Good morning, and welcome everyone to Selective Third Quarter 2023 Corporate Update 00:00:35.346 -- 00:00:40.588 and Financial Results Conference Call. Joining me on the call today with prepared remarks 00:00:40.588 -- 00:00:44.249 are Dr. André Choulika, our Chief Executive Officer, Dr. 00:00:44.249 -- 00:00:47.170 Bing Wang, our Chief Financial Officer, and Dr. 00:00:47.170 -- 00:00:50.552 Mark Frittini, our Chief Medical Officer. 00:00:50.552 -- 00:00:54.614 Yesterday evening, Selectus issued a press release reporting a corporate and business 00:00:54.614 -- 00:00:57.176 update for the third quarter 2023, 00:00:57.176 -- 00:01:02.467 and its financial results for the nine-month period ended September 30th, 2023. 00:01:03.159 -- 00:01:07.681 As a reminder, we will make statements regarding Selectus' financial outlook, including 00:01:07.681 -- 00:01:12.744 the sufficiency of cash-to-fund operations, in addition to its manufacturing, regulatory, 00:01:12.744 -- 00:01:18.826 and product development status and plans, and product development of its licensed partners. 00:01:18.826 -- 00:01:22.688 These forward statements, which are based on our management's current ex...